Content Rules, Inc.

What pharma labeling can teach us about content reuse | Content rules | woman looking at prescription bottle

What Pharma Labeling Content Can Teach Us About Content Reuse

Because labeling is global and requires localization, pharma companies gain even more benefit from content reuse.

Pharma Deserves Better

Legacy tools and processes no longer support the business objectives for pharma. The only way to meet the growing demands for more content, faster, is to adopt a structured content ecosystem.

The CDS is Dead! Long Live the CDS!

The Company Core Data Sheet (CDS or CCDS) is one of the most important documents a pharmaceutical company creates. The CDS is a working document that contains information about the pharmaceutical product. It includes information from multiple sources, such as clinical trial data systems, clinical report documents, CMC data systems,

Getting Granular with eCTD v4.0

We talk a lot about the goal of enterprise content strategy for pharma: to help speed up the process of making safe, effective medicines. One part of achieving that goal is to get content through regulatory approval faster. To speed up review and approval, pharma content must be: Easy to

The pharma industry has come together to develop technical solutions that speed time-consuming processes and reduce errors that can cause risk to the business and ultimately to patients. The goals of these technical solutions include: Facilitate digital information exchange between CROs, sites, sponsors, regulators, and EHR systems Guide decisions at

Solving Pharma Content Challenges

In The Unique Challenges of Pharma Content, we discuss challenges faced by pharmaceutical companies in the creation and management of content. Here is a short list: Takes too long to create, approve, and deliver content Cannot leverage or reuse content across documents and organizational silos Cannot manage the high volume

MedTech: The Time is Now for Structured Content

I recently came across a great commentary in the August 2021 issue of “Pharma Technology Focus.” The article is titled, “MDR set to transform how MedTech firms approach content management,” written by Barbara Peraltor, Director of Life Science Solutions at Amplexor. Barbara makes a number of pertinent points in the

Is Structured Content Ready for Pharma?

I’ve had more than one conversation over the past several years about whether pharmaceutical companies were “ready” for structured content. After all, many of the benefits of structured content roll up into one key business need: scale. And scale — the ability to produce a lot of content quickly, accurately,